Table 2.
Clinical findings in patient cohorts
| Parameter | Group A (n = 21) | Group B (n = 12) | P | 
|---|---|---|---|
| Posttransplantation day of initial protocol biopsy (d) | 0.90c | ||
| mean ± SD | 49 ± 29 | 44 ± 18 | |
| range | 22 to 115 | 24 to 81 | |
| Posttransplantation day of most recent follow-up (d) | 0.53c | ||
| mean ± SDa | 852 ± 515 | 887 ± 218 | |
| range | 324 to 1956 | 504 to 1267 | |
| SCr (mg/dl) | |||
| at diagnostic/initial biopsy | |||
| mean ± SD | 1.2 ± 0.3 | 1.2 ± 0.4 | 0.84d | 
| range | 0.7 to 1.8 | 0.5 to 2.2 | |
| at 6-mo protocol biopsy | |||
| mean ± SD | 1.3 ± 0.2 | 1.4 ± 0.5 | 0.50d | 
| range | 0.8 to 1.7 | 1.0 to 2.7 | |
| at 12-mo protocol biopsy | |||
| mean ± SDb | 1.3 ± 0.3 | 1.4 ± 0.7 | 0.65d | 
| range | 0.9 to 2.3 | 1.0 to 3.1 | |
| at most recent follow-up | |||
| mean ± SDa | 1.3 ± 0.3 | 1.3 ± 0.2 | 0.59d | 
| range | 0.9 to 2.3 | 1.1 to 1.7 | |
| Graft losses (n [%]) | 1 (5) | 2 (17) | 0.54e | 
Does not include the three patients whose grafts were lost.
n = 19 for group A, n = 9 for group B.
By Wilcoxon rank sum test.
By t test.
By Fisher exact test.